| 0.8 |
2.3 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.4 |
1.7 |
GO:0001969 |
activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) positive regulation of activation of membrane attack complex(GO:0001970) positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.4 |
1.2 |
GO:0061117 |
negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
| 0.3 |
1.4 |
GO:0032849 |
positive regulation of cellular pH reduction(GO:0032849) |
| 0.3 |
1.3 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.3 |
0.9 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.3 |
1.8 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.2 |
1.0 |
GO:0051712 |
positive regulation of killing of cells of other organism(GO:0051712) |
| 0.2 |
0.7 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.2 |
0.6 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.2 |
4.0 |
GO:0002504 |
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.2 |
0.7 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.2 |
2.1 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.1 |
0.8 |
GO:0043045 |
DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.1 |
9.8 |
GO:0030183 |
B cell differentiation(GO:0030183) |
| 0.1 |
0.6 |
GO:0060049 |
regulation of protein ADP-ribosylation(GO:0010835) regulation of protein glycosylation(GO:0060049) |
| 0.1 |
0.5 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 |
0.3 |
GO:0060454 |
positive regulation of gastric acid secretion(GO:0060454) regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.1 |
0.4 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.1 |
1.0 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.1 |
0.4 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 0.1 |
0.7 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.1 |
0.5 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 |
0.3 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.1 |
0.2 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.1 |
0.6 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 0.1 |
1.3 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.1 |
0.5 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.1 |
0.2 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.1 |
0.5 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.1 |
0.7 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.1 |
0.3 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
0.4 |
GO:0006562 |
proline catabolic process(GO:0006562) |
| 0.1 |
0.2 |
GO:0090034 |
peptidyl-lysine deacetylation(GO:0034983) regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.1 |
0.1 |
GO:0002890 |
negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 0.1 |
0.5 |
GO:0051294 |
establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
| 0.1 |
0.9 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.1 |
0.7 |
GO:0098927 |
early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 0.1 |
1.0 |
GO:1904031 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.1 |
1.4 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.1 |
0.4 |
GO:0042416 |
dopamine biosynthetic process(GO:0042416) |
| 0.1 |
0.6 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.1 |
0.3 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 |
0.5 |
GO:0097061 |
dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
| 0.0 |
0.3 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 |
0.3 |
GO:0010648 |
negative regulation of signal transduction(GO:0009968) negative regulation of cell communication(GO:0010648) negative regulation of signaling(GO:0023057) negative regulation of response to stimulus(GO:0048585) |
| 0.0 |
0.1 |
GO:0060896 |
neural plate anterior/posterior regionalization(GO:0021999) neural plate pattern specification(GO:0060896) neural plate regionalization(GO:0060897) |
| 0.0 |
0.3 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.0 |
0.3 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
| 0.0 |
1.4 |
GO:0019882 |
antigen processing and presentation(GO:0019882) |
| 0.0 |
3.4 |
GO:0042113 |
B cell activation(GO:0042113) |
| 0.0 |
0.1 |
GO:0043163 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.0 |
0.1 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.0 |
0.3 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.0 |
0.6 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.0 |
0.2 |
GO:0010523 |
negative regulation of calcium ion transport into cytosol(GO:0010523) |
| 0.0 |
0.1 |
GO:0071312 |
cellular response to alkaloid(GO:0071312) cellular response to caffeine(GO:0071313) |
| 0.0 |
0.5 |
GO:0048843 |
negative regulation of axon extension involved in axon guidance(GO:0048843) negative chemotaxis(GO:0050919) |
| 0.0 |
0.2 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.0 |
0.2 |
GO:0050666 |
regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
| 0.0 |
0.1 |
GO:0019056 |
modulation by virus of host transcription(GO:0019056) regulation of sprouting of injured axon(GO:0048686) positive regulation of sprouting of injured axon(GO:0048687) regulation of axon extension involved in regeneration(GO:0048690) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.0 |
0.1 |
GO:0048865 |
stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
| 0.0 |
0.2 |
GO:0042797 |
5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.0 |
0.1 |
GO:0060259 |
regulation of feeding behavior(GO:0060259) |
| 0.0 |
0.2 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.0 |
0.3 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.0 |
0.3 |
GO:0030219 |
megakaryocyte differentiation(GO:0030219) |
| 0.0 |
0.2 |
GO:0009396 |
histidine metabolic process(GO:0006547) folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.0 |
0.3 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.0 |
0.1 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.0 |
2.3 |
GO:0050852 |
T cell receptor signaling pathway(GO:0050852) |
| 0.0 |
0.1 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.1 |
GO:0030277 |
epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.0 |
0.5 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
0.1 |
GO:0060398 |
regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.0 |
0.5 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.0 |
0.1 |
GO:0072148 |
epithelial cell fate commitment(GO:0072148) |
| 0.0 |
0.1 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
| 0.0 |
0.1 |
GO:0061081 |
positive regulation of macrophage cytokine production(GO:0060907) positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
| 0.0 |
0.1 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.0 |
1.1 |
GO:0006521 |
regulation of cellular amino acid metabolic process(GO:0006521) |
| 0.0 |
0.2 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.0 |
0.1 |
GO:0060113 |
inner ear receptor cell differentiation(GO:0060113) |
| 0.0 |
0.1 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 |
0.3 |
GO:0009070 |
serine family amino acid biosynthetic process(GO:0009070) |
| 0.0 |
0.7 |
GO:0017156 |
calcium ion regulated exocytosis(GO:0017156) |
| 0.0 |
0.2 |
GO:0048265 |
response to pain(GO:0048265) |
| 0.0 |
0.3 |
GO:0031424 |
keratinization(GO:0031424) |
